Wegovy, Ozempic: The barriers to accessing these weight loss drugs

  • 📰 FoxBusiness
  • ⏱ Reading Time:
  • 39 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 53%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

Doctors tell FOX Business that there are a handful of barriers keeping people from being able to take Wegovy and Ozempic including insurance coverage, high cost and availability issues.

"While product continues to be manufactured and shipped, patients in some areas of the country will experience delays with these doses," Novo Nordisk said in a statement, adding that patients "concerned with continuity of treatment, should contact their healthcare provider."

Studies have shown that patients who discontinue semaglutide, will regain two-thirds of the weight they lost within the subsequent year, according to McGowan. chronic, progressive, and relapsing diseaseThis will ultimately create a barrier "for patients who may be opposed to using a medication long-term and for healthcare providers who, unfortunately, often do not view obesity as the chronic disease that it is," he continued.

Even though this drug is used to treat a medical disease, according to McGowan and Mullally, patients still run into insurance issues.Insurance coverage"Only a small minority of commercial insurance programs cover Wegovy, and government insurance explicitly excludes coverage of anti-obesity drugs," he continued.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Those in search of weight loss product with no insurance coverage Message me directly Ozempic Mounjaro Wegovy Duromine Saxenda

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 458. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

WeightWatchers buys telehealth platform Sequence, facilitating access to Ozempic and WegovyThe diet company is hoping to offer members the ability to meet with clinicians who can prescribe obesity and diabetes medications. 🖤 What good is this if it’s not covered by insurance. $1600/month is out of reach for anyone who actually needs it! Move more, eat less. Now give me money for this new diet.
Source: NBCNewsHealth - 🏆 707. / 51 Read more »

Weight Watchers jumping into prescription weight loss drug business with medicines such as Ozempic, WegovyThe company said this week it will buy Sequence, a telehealth service that subscriber patients can use to connect with doctors who can prescribe weight loss and diabetes drugs.
Source: clevelanddotcom - 🏆 301. / 63 Read more »

WSJ News Exclusive | WeightWatchers Moves Into the Ozempic Market With Telehealth DealThe weight-management company is buying digital health company Sequence, which offers telehealth visits with doctors. Isn't moving into the Ozempic market an implicit admission that their product doesn't work. 'You can totally lose weight and keep it off with our points system... but on second thought, here's some drugs.' 황금으로 만든 골든 이글이 필요해
Source: WSJhealth - 🏆 413. / 53 Read more »